Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative exemestane or letrozole with or without celecoxib for estrogen receptor-positive early breast cancer
ISRCTN09768535Phase 3Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of exemestane, letrozole and celecoxib in breast cancer (4 arms), sponsored by University Hospitals Birmingham. Primary endpoint: Objective clinical response. Started Aug 2007; status: completed.
02
Drugs
exemestaneletrozolecelecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN09768535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN09768535.